Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction

Microcirculation

Volumn 9, Issue 3, 2002, Pages 147-160

  Granger, Joey P ^b   Alexander, Barbara T ^c   Llinas, Maria T ^c   Bennett, William A ^a   Khalil, Raouf A ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Cytokines; Endothelin; Kidney; Nitric oxide; Pregnancy

Indexed keywords

ANOXIA; BLOOD VESSEL; FEMALE; HUMAN; ISCHEMIA; MICROCIRCULATION; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; REVIEW; VASCULARIZATION;

ANOXIA; BLOOD VESSELS; FEMALE; HUMANS; ISCHEMIA; MICROCIRCULATION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 0036654207     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800137     Document Type: Review

References (92)

1. Abitbol MM, Gallo GR, Pirani CL, Ober WB. (1976). Production of experimental toxemia in the pregnant rabbit. Am J Obstet Gynecol 124(5):460-470.
2. Abitbol MM, Pirani CL, Ober WB, Driscoll SG, Cohen MW. (1976). Production of experimental toxemia in the pregnant dog. Obstet Gynecol 48(5):537-548.
3. Alexander BT, Miller MT, Kassab SE, Novak J, Reckelhoff JF, Kruckeberg WC, Granger JP. (1999). Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33(1 pt 2):435-439.
4. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. (2001). Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37(4):1191-1195.
5. Alexander BT, Rinewalt AN, Cockrell KL, Bennett WA, Granger JP. (2001). Endothelin-A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37(2):485-489.
6. Alexander BT, Cockrell KL, Sedeek M, Granger JP. (2001). Role of the renin-angiotensin system in meditating the hypertension produced by chronic reductions in uterine perfusion pressure in the pregnant rat. Hypertension 38(3):742-745.
7. Alexander BT, Bennett WA, Khalil RA, Granger JP. (2001). Preeclampsia: linking placental isthemia with cardiovascular-renal dysfunction. News In Physiological Sciences 16:282-286.
8. Andrew RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. (1990). The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 163(3):935-938.
9. August P, Lindheimer MD. (1995). Pathophysiology of preeclampsia. In: Hypertension, 2nd edition (JL Laragh and BM Brenner, Eds.) Raven Press, Ltd. New York. 2407-2426.
10. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. (1996). Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy. Clin Sci (Lond) 91(6):711-718.
11. Barron LA, Giardina JB, Granger JP, Khalil RA. (2001). High salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension 38(3 pt 2):730-735.
12. Bennett WA, Lagoo-Deenadayalan S, Stopple JA, Barber WH, Hale E, Brackin MN, Cowan BD. (1998). Cytokine expression by first trimester human chorionic villi. Am J Reprod Immunol 40(5):309-318.
13. Benyo DF, Miles TM, Conrad KP. (1997). Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endo Metab. 82(5): 1582-1588.
14. Boffa MC, Valsecchi L, Fausto A, Gozin D, Vigano' D'Angelo S, Safa O, Castiglioni MT, Amiral J, D'Angelo A. (1998). Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost 79(6):1092-1095.
15. Bontis J, Vavilis D, Agorastos T, Zournatzi V, Konstantinidis T, Tagou K. (1995). Maternal plasma level of thrombomodulin is increased in mild preeclampsia. Eur J Obstet Gynecol Reprod Biol 60(2): 139-141.
16. Brown MA. (1995). The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 22(11):781-791.
17. Brosens IA, Robertson WB, Dixon HG. (1972). The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1:177-191.
18. Cavanagh D, Rao PS, Tung KS, Gaston L. (1974). Eclamptogenic toxemia: the development of an experimental model in the subhuman primate. Am J Obstet Gynecol 120(2):183-196.
19. Cavanagh D, Rao PS, Tsai CC, O'Connor TC. (1977). Experimental toxemia in the pregnant primate. Am J Obstet Gynecol 128(1):75-85.
20. Combs CA, Katz MA, Kitzmiller JL, Brescia RJ. (1993). Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 169(1):215-223.
21. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. (2000). Altered circulating levels of adhesion molecules at 18 weeks gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 182(2):321-325.
22. Conrad KP. (1990). Animal models of pre-eclampsia: do they exist? Fetal Medicine Review 2:67-88.
23. Conrad KP, Miles TM, Benyo DF. (1998). Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40(2):102-111.
24. Conrad KP, Kerchner LJ, Mosher MD. (1999). Plasma and 24-hour NO (x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO (x) diet. Am J Physiol 277(1 pt 2):F48-57.
25. Conrad KP, Benyo DF. (1997). Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37(3):240-249.
26. Cotran RS, Pober JS. (1990). Cytokine-endothelial interactions in inflammation, immunity and vascular injury. J Am Soc Nephrol 1(3):225-235.
27. Crews JK, Herrington JN, Granger JP, Khalil RA. (2000). Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rats. Hypertension. 35(1 pt 2):367-372.
28. Damsky CH, Fitzgerald ML, Fisher SJ. (1992). Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89(1):210-222.
29. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. (1994). Integrin switching regulates normal trophoblast invasion. Development. 120(12):3657-3666.
30. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Wolman I, Shenhav M, Lessing JB. (1998). Plasma soluble endothelial selectin is elevated in women with preeclampsia. Hum Reprod 13(12):3537-3541.
31. Davidge ST, Stranko CP, Roberts JM. (1996). Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174(3):1008-1013.
32. Deng L, Bremme K, Hansson LO, Blomback M. (1994). Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 84(6):941-945.
33. Eder DJ, McDonald MT. (1987). A role for brain angiotensin II in experimental pregnancy-induced hypertension in laboratory rats. Clin Exp Hyper Preg B6:431-451.
34. Faas MM, Schuiling GA, Baller JFW, Visscher CA, Bakker WW. (1994). A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171(1):158-164.
35. Felfenig-Boehm D, Salat A, Vogl SE, Murabito M, Felfernig M, Schmidt D, Mittlboeck M, Husslein P, Mueller MR. (2000). Early detection of preeclampsia by determination of platelet aggregation. Thromb Res 98(2):139-146.
36. Fisher SJ, Roberts JM. (1999). Defects in placentation and placental perfusion. In: Chesley's Hypertensive Disorders in Pregnancy, 2nd edition (Linhheimer MD, Roberts JM, and Cunningham FG, Eds.) Appleton & Lange. Stanford, CT. 377-394.
37. Frohlich MA, Datta S, Corn SB. (1998). Thrombopoietin in normal pregnancy and preeclampsia. Am J Obstet Gynecol 179:100-104.
38. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. (1996). Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 97(2):540-550.
39. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. (1997). Regulation of human placental development by oxygen tension. Science 277(5332):1669-1672.
40. Gerretsen G, Huisjes HJ, Elema JD. (1981). Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88(9):876-881.
41. Goeschen K, Henkel E, Behrens O. (1993). Plasma prostacyclin and thromboxane concentrations in 160 normotensive, hypotensive, and preeclamptic patients during pregnancy, delivery, and the post-partum period. J Perinat Med 21(6):481-489.
42. Granger JP, Schnackenberg C. (2000). Renal mechanisms of angiotensin II-induced hypertension. Semin Nephrol 20(5):417-425.
43. Granger JP, Alexander BT. (2000). Abnormal pressure natriuresis in hypertension: role of nitric oxide. Acta Physiologica Scandinavia 168(1):161-168.
44. Granger JP, Bennett WM, Alexander BT, Cockrell KL, Whitworth NS. (1999). Long-term elevation of plasma TNF-alpha increases arterial pressure and reduces kidney function in pregnant rats. Hypertension 34(2):337.
45. Granger JP, Alexander BT, Bennett WA, Khalil RA. (2001). Pathophysiology of pregnancy-induced hypertension. Am J Hypertension 14(6 pt 2):178-185.
46. Granger JP, Alexander BT, Abram SR, Reckelhoff JF, Wilson J, Rinewalt AN. (2001). Chronic reductions in uterine perfusion pressure in the pregnant rat produces hypertension and reduces pressure-natriuresis. Hypertension 36(4):682.
47. Gratacos E, Casals E, Sanllehy C, Cararach V, Alsonso PL, Fortuny A. (1996). Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 75(10): 896-901.
48. Hanretty KP, Whittle MJ, Rubin PC. (1988). Doppler uteroplacental waveforms in pregnancy-induced hypertension: a re-appraisal. Lancet 1(8590):850-852.
49. Henriksen T. (2000). The role of lipid oxidation and oxidative lipid derivatives in the development of preeclampsia. Semin Perinatol 24(1):29-32.
50. Heyl W, Handt S, Reister F, Gehlen J, Schroder W, Mittermayer C, Rath W. (1999). Elevated soluble adhesion molecules in women with preeclampsia. Do cytokines like tumor necrosis factor-alpha and interleukin-1 beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol 86(1):35-41.
51. Hodari AA. (1967). Chronic uterine ischemia and reversible experimental "toxemia of pregnancy." Am J Obstet Gynecol 97(5):597-607.
52. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. (1998). Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism 47(10):1281-1288.
53. Hubel CA, Roberts JM. (1999). Lipid metabolism and oxidative stress. In: Chesley's Hypertensive Disorders in Pregnancy, 2nd edition (MD Linhheimer, JM Roberts, and FG Cunningham, Eds.) Appleton & Lange. Stanford, CT. 453-475.
54. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. (1998). Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31(5):1065-1069.
55. Konijnenberg A, Stokkers EW, van der Post JA, Schaap MC, Boer K, Bleker OP, Sturk A. (1997). Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 176(2):461-469.
56. Krauss T, Kuhn W, Lakoma C, Augustin HG. (1997). Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 177:443-449.
57. Lin H, Mossman TR, Guilbert L, Tuntipopipat S, Wegmann TG. (1993). Synthesis of T-helper-2 cytokines at the maternal-fetal interface. J Immunol 151(9):4562-4573.
58. Llinas MT, Alexander BT, Abram SR, Sedeek M, Granger JP. (2001). Enhanced production of thromboxane A2 in response to chronic reductions in uterine perfusion pressure in pregnant rats. FASEB J 15:A788.
59. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. (1995). Fatty acid pattern of esterified and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 102(7): 530-537.
60. Losonczy G, Brown G, Venuto RC. (1992). Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am J Med Sci 303(4):233-240.
61. Mastrogiannis DS, O'Brien WF, Krammer J, Benoit R. (1991). Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 165(6 pt 1):1711-1716.
62. McMahon LP, Redman CW, Firth JD. (1993). Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Lond) 85(4):417-424.
63. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ. (1999). Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 282(4):356-362.
64. Murai JT, Muzykanskiy E, Taylor RN. (1997). Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 46(8):963-967.
65. Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, Ademoglu E, Uysal M. (1999). Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 48(4):247-250.
66. Ogden E, Hildebrand CJ, Page EW. (1940). Rise in blood pressure during ischemia of the gravid uterus. Proc Soc Exp Biol Med 43:49-51.
67. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. (1991). Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98(7):648-655.
68. Pober JS, Cotran RS. (1990). Cytokines and endothelial cell biology. Physiol Rev 70(2):427-451.
69. Raitakari OT, Celermajer DS. (2000). Testing for endothelial dysfunction. Ann Med 32(5):293-304.
70. Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. (1999). Nitric oxide production with preeclampsia. Obstet Gynecol 93(8):442-445.
71. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale E, Martin JN, Bennett WA. (1999). Expression of the placental cytokines tumor necrosis factor alpha, interleukin-1 beta, and interleukin-10 is increased in preeclampsia. Am J Obstet Gynecol 181(4):915-920.
72. Roberts JM, Taylor RN, Goldfien A. (1991). Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4(8):700-708.
73. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. (1989). Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161(5):1200-1204.
74. Rodesch F, Simon P, Donner C, Jauniaux E. (1992). Oxygen requirements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 80(2):283-285.
75. Roggensack AM, Zhang Y, Davidge ST. (1999). Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33(1): 83-89.
76. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. (1997). Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 89(3):403-408.
77. Shaamash AH, Elsnosy ED, Makhlouf AM, Zakhari MM, Ibrahim OA, EL-dien HM. (2000). Maternal and fetal serum nitric oxide concentration in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 68(3):207-214.
78. Shaarawy M, Didy HE. (1996). Thrombomodulin, plasminogen activator inhibitor type-1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 55(2):135-139.
79. Sladek SM, Magness RR, Conrad KP. (1997). Nitric oxide and pregnancy. Am J Physiol 272(2 pt 2):R441-R463.
80. Stark JM. (1993). Preeclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 100(2): 105-109.
81. Sud SS, Gupta I, Dhaliwal LK, Kaur B, Ganguly NK. (1999). Serial plasma fibronectin levels in pre-eclamptic and normotensive women. Int J Gynaecol Obstet 66(2):123-128.
82. Taylor RN, Varma M, Teng NN, Roberts JM. (1990). Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71(6):1675-1677.
83. Taylor RN, de Groot CJ, Cho YK, Lim KH. (1998). Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 16(1):17-31.
84. Taylor RN, Roberts JM. (1999). Endothelial cell dysfunction. In: Chesley's Hypertensive Disorders in Pregnancy, 2nd edition (MD Linhheimer, JM Roberts, and FC Cunningham, Eds.) Appleton & Lange. Stanford, CT. 395-429.
85. Wallenburg HCS. (1988). Hemodynamics in hypertensive pregnancy. In: Handbook of Hypertension (PC Rubin, Ed.) Amsterdam: Elsevier Science Publishers B.V. 257-266.
86. Walsh SW. (1998). Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16(1):93-104.
87. Wang Y, Walsh SW. (1996). TNF alpha concentrations and mRNA expression are increased in pre-eclamptic placentas. J Reprod Immunol 32(2):157-169.
88. Wegmann TG, Lin H, Guilbert L, Mosmann TH. (1993). Bidirectional cytokine interactions in the materno-fetal relationship: successful allopregnancy is a Th2 phenomenon? Immunol Today 14(7):353-356.
89. Wilkins FC, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP. (1995). Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol 268(2 pt 2):R375-R381.
90. Woods LL. (1989). Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol 257(6 pt 2):R1558-R1561.
91. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. (1997). Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99(9):2139-2151.
92. Zhou Y, Chiu K, Brescia RJ, Combs CA, Katz MA, Kitzmiller JL, Heilbron DC, Fisher SJ. (1993). Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys. Am J Obstet Gynecol 169(1):224-229.